Cue Biopharma, Inc. (CUE) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $27.47M | +195.7% |
| 2024 | $9.29M | +69.2% |
| 2023 | $5.49M | +341.0% |
| 2022 | $1.25M | -91.7% |
| 2021 | $14.94M | +373.7% |
| 2020 | $3.15M | -8.8% |
| 2019 | $3.46M | +202.7% |
| 2018 | $1.14M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $27.47M | +195.7% |
| 2024 | $9.29M | +69.2% |
| 2023 | $5.49M | +341.0% |
| 2022 | $1.25M | -91.7% |
| 2021 | $14.94M | +373.7% |
| 2020 | $3.15M | -8.8% |
| 2019 | $3.46M | +202.7% |
| 2018 | $1.14M | — |